One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Childhood-onset inflammatory bowel disease and chronic non-bacterial osteomyelitis: a Swedish nationwide cohort study 2002-2022 Open Access
doi : 10.1093/ecco-jcc/jjaf007
Volume 19, Issue 2, February 2025
Severe obesity, a susceptibility factor for developing inflammatory bowel disease: results of a population-based study
doi : 10.1093/ecco-jcc/jjaf010
The impact of advanced medical therapies on time to resection and colorectal cancer outcomes in ulcerative colitis patients undergoing colectomy Open Access
doi : 10.1093/ecco-jcc/jjaf015
Intestinal epithelial PTPN23 is essential for gut barrier integrity and prevention of fatal bacterial translocation Open Access
doi : 10.1093/ecco-jcc/jjaf016
Gasdermin B modulates intestinal epithelial homeostasis via regulating hyperactive unfolded protein response in Crohn’s disease
doi : 10.1093/ecco-jcc/jjaf012
Machine learning and metabolomics identify biomarkers associated with the disease extent of ulcerative colitis Open Access
doi : 10.1093/ecco-jcc/jjaf020
Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal adenocarcinoma: a case-cohort study
doi : 10.1093/ecco-jcc/jjaf022
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host–Microbiome–Metabolomic Signatures Open Access
doi : 10.1093/ecco-jcc/jjae189
Systematic review on definitions of intestinal ultrasound treatment response and remission in inflammatory bowel disease
doi : 10.1093/ecco-jcc/jjaf011
Assessment of activity and severity of inflammatory bowel disease in cross-sectional imaging techniques: a systematic review
doi : 10.1093/ecco-jcc/jjaf023
The Costs of Home Monitoring by Telemedicine vs Standard Care for Inflammatory Bowel Diseases—A Danish Register-Based, 5-Year Follow-up Study Open Access
doi : 10.1093/ecco-jcc/jjae120
Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn’s Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials Open Access
doi : 10.1093/ecco-jcc/jjae128
Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN Cohort
doi : 10.1093/ecco-jcc/jjae130
Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
doi : 10.1093/ecco-jcc/jjae131
Pharmacological Inhibition of N-Acylethanolamine Acid Amidase (NAAA)Â Mitigates Intestinal Fibrosis Through Modulation of Macrophage Activity Open Access
doi : 10.1093/ecco-jcc/jjae132
Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis
doi : 10.1093/ecco-jcc/jjae133
Deficiency in Epithelium RAD50 Aggravates UC via IL-6-Mediated JAK1/2-STAT3 Signaling and Promotes Development of Colitis-Associated Cancer in Mice
doi : 10.1093/ecco-jcc/jjae134
Dynamics of Gut Microbiota After Fecal Microbiota Transplantation in Ulcerative Colitis: Success Linked to Control of Prevotellaceae Open Access
doi : 10.1093/ecco-jcc/jjae137
Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire
doi : 10.1093/ecco-jcc/jjae138
Eicosatetraynoic Acid Regulates Profibrotic Pathways in an Induced Pluripotent Stem Cell–Derived Macrophage-Human Intestinal Organoid Model of Crohn’s Disease
doi : 10.1093/ecco-jcc/jjae139
Novel Microbial Engraftment Trajectories Following Microbiota Transplant Therapy in Ulcerative Colitis
doi : 10.1093/ecco-jcc/jjae142
A pro-inflammatory diet is associated with growth and virulence of Escherichia coli in pediatric Crohn’s disease
doi : 10.1093/ecco-jcc/jjaf018
Prevalence, incidence, and mortality of inflammatory bowel disease in the Netherlands: development and external validation of machine learning models Open Access
doi : 10.1093/ecco-jcc/jjaf017
Adverse maternal outcomes after vaginal versus caesarean delivery in women with Crohn’s disease and prior perianal surgery: a population-based study
doi : 10.1093/ecco-jcc/jjaf028
Janus kinase inhibitors in the management of acute severe ulcerative colitis: a comprehensive review
doi : 10.1093/ecco-jcc/jjaf021
Comparative Efficacy of Novel Biologics, Anti-tumor Necrosis Factor Agents, and Immunomodulators to Prevent Postoperative Recurrence in Crohn’s Disease: A Systematic Review and Network Meta-analysis
doi : 10.1093/ecco-jcc/jjae143
Systematic review: severe endoscopic lesions in inflammatory bowel disease
doi : 10.1093/ecco-jcc/jjaf029
The Groupe d’Etude sur les Affections Inflammatoires Digestives (GETAID): 40 Years of a Family Story in Inflammatory Bowel Disease
doi : 10.1093/ecco-jcc/jjae122
Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease? Free
doi : 10.1093/ecco-jcc/jjae136
Correction to: Ulcerative Colitis Severity Classification and Localized Extent (UC-SCALE): An Artificial Intelligence Scoring System for a Spatial Assessment of Disease Severity in Ulcerative Colitis Free
doi : 10.1093/ecco-jcc/jjaf031
